
Cell Chemical Biology p. 1282 - 1293 (2016)
Update date:2022-08-10
Topics:
Chen, John J.
Genereux, Joseph C.
Suh, Eul Hyun
Vartabedian, Vincent F.
Rius, Bibiana
Qu, Song
Dendle, Maria T.A.
Kelly, Jeffery W.
Wiseman, R. Luke
Transthyretin (TTR) is a tetrameric serum protein associated with multiple systemic amyloid diseases. In these disorders, TTR aggregates in extracellular environments through a mechanism involving rate-limiting dissociation of the tetramer to monomers, which then misfold and aggregate into soluble oligomers and amyloid fibrils that induce toxicity in distal tissues. Using an assay established herein, we show that highly destabilized, aggregation-prone TTR variants are secreted as both native tetramers and non-native conformations that accumulate as high-molecular-weight oligomers. Pharmacologic chaperones that promote endoplasmic reticulum (ER) proteostasis of destabilized TTR variants increase their fraction secreted as a tetramer and reduce extracellular aggregate populations. In contrast, disrupting ER proteostasis reduces the fraction of destabilized TTR secreted as a tetramer and increases extracellular aggregates. These results identify ER proteostasis as a factor that can affect conformational integrity and thus toxic aggregation of secreted amyloidogenic proteins associated with the pathology of protein aggregation diseases.
website:http://www.alwaychem.com
Contact:+86-532-8586-4000, 8586-5000
Address:NO.51, TAIPING ROAD, QINGDAO, CHINA. 266001
Contact:+1-284-4950244
Address:Box 3069, Road Town, Tortola, British Virgin Islands
Shanghai Dano Pharmaceutical Co.,Ld.(expird)
Contact:+86-592-6266840
Address:Building 1 Room 512, 720 Cailun Rd, Zhangjiang High-Tech Park, Shanghai 201203, China
Nanjing Habo Medical Technology Co., Ltd.
Contact:025-85769882
Address:No.108. Ganjiabian east. Qixia District .Nanjing
Zhejiang Linhai Xinhua Chemicals Factory
Contact:0086-13661858911
Address:Xunqiao Development Zone, Linhai, Zhejiang, China
Doi:10.1016/j.carres.2020.108072
(2020)Doi:10.1021/ol8013478
(2008)Doi:10.1021/ja00339a022
(1983)Doi:10.1002/cbic.201100067
(2011)Doi:10.1080/14786419.2018.1561681
(2020)Doi:10.1016/j.tet.2010.03.040
(2010)